UniProtKB - Q13950 (RUNX2_HUMAN)
(max 400 entries)x
Your basket is currently empty.
Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)
Protein
Runt-related transcription factor 2
Gene
RUNX2
Organism
Homo sapiens (Human)
Status
Functioni
Transcription factor involved in osteoblastic differentiation and skeletal morphogenesis. Essential for the maturation of osteoblasts and both intramembranous and endochondral ossification. CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, osteocalcin, osteopontin, bone sialoprotein, alpha 1(I) collagen, LCK, IL-3 and GM-CSF promoters. In osteoblasts, supports transcription activation: synergizes with SPEN/MINT to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE) (By similarity). Inhibits KAT6B-dependent transcriptional activation.By similarity1 Publication
GO - Molecular functioni
- ATP binding Source: InterPro
- bHLH transcription factor binding Source: Ensembl
- chromatin binding Source: Ensembl
- protein domain specific binding Source: Ensembl
- repressing transcription factor binding Source: Ensembl
- RNA polymerase II core promoter proximal region sequence-specific DNA binding Source: Ensembl
- RNA polymerase II core promoter sequence-specific DNA binding Source: Ensembl
- RNA polymerase II transcription factor activity, sequence-specific DNA binding Source: GO_Central
- transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding Source: Ensembl
- transcription factor activity, sequence-specific DNA binding Source: ProtInc
GO - Biological processi
- BMP signaling pathway Source: BHF-UCL
- cell maturation Source: Ensembl
- cellular response to BMP stimulus Source: BHF-UCL
- chondrocyte development Source: Ensembl
- chondrocyte differentiation Source: GO_Central
- embryonic cranial skeleton morphogenesis Source: Ensembl
- embryonic forelimb morphogenesis Source: Ensembl
- endochondral ossification Source: Ensembl
- hemopoiesis Source: GO_Central
- negative regulation of smoothened signaling pathway Source: Ensembl
- negative regulation of transcription, DNA-templated Source: UniProtKB
- neuron differentiation Source: GO_Central
- odontogenesis of dentin-containing tooth Source: Ensembl
- ossification Source: UniProtKB
- osteoblast development Source: Ensembl
- osteoblast differentiation Source: UniProtKB
- osteoblast fate commitment Source: Ensembl
- positive regulation of cell proliferation Source: Ensembl
- positive regulation of chondrocyte differentiation Source: Ensembl
- positive regulation of osteoblast differentiation Source: Ensembl
- positive regulation of transcription, DNA-templated Source: UniProtKB
- positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus Source: BHF-UCL
- regulation of cell differentiation Source: GO_Central
- regulation of fibroblast growth factor receptor signaling pathway Source: Ensembl
- regulation of odontogenesis of dentin-containing tooth Source: Ensembl
- regulation of transcription from RNA polymerase II promoter Source: GO_Central
- stem cell differentiation Source: Ensembl
- T cell differentiation Source: Ensembl
Keywordsi
| Molecular function | DNA-binding |
| Biological process | Transcription, Transcription regulation |
Enzyme and pathway databases
| Reactomei | R-HSA-2032785. YAP1- and WWTR1 (TAZ)-stimulated gene expression. |
| SignaLinki | Q13950. |
| SIGNORi | Q13950. |
Names & Taxonomyi
| Protein namesi | Recommended name: Runt-related transcription factor 2Alternative name(s): Acute myeloid leukemia 3 protein Core-binding factor subunit alpha-1 Short name: CBF-alpha-1 Oncogene AML-3 Osteoblast-specific transcription factor 2 Short name: OSF-2 Polyomavirus enhancer-binding protein 2 alpha A subunit Short name: PEA2-alpha A Short name: PEBP2-alpha A SL3-3 enhancer factor 1 alpha A subunit SL3/AKV core-binding factor alpha A subunit |
| Gene namesi | Name:RUNX2 Synonyms:AML3, CBFA1, OSF2, PEBP2A |
| Organismi | Homo sapiens (Human) |
| Taxonomic identifieri | 9606 [NCBI] |
| Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
| Proteomesi |
|
Organism-specific databases
| HGNCi | HGNC:10472. RUNX2. |
Subcellular locationi
GO - Cellular componenti
- cytoplasm Source: Ensembl
- nuclear chromatin Source: BHF-UCL
- nucleoplasm Source: HPA
- nucleus Source: GO_Central
- transcription factor complex Source: Ensembl
Keywords - Cellular componenti
NucleusPathology & Biotechi
Involvement in diseasei
Cleidocranial dysplasia (CLCD)14 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionAutosomal dominant skeletal disorder with high penetrance and variable expressivity. It is due to defective endochondral and intramembranous bone formation. Typical features include hypoplasia/aplasia of clavicles, patent fontanelles, wormian bones (additional cranial plates caused by abnormal ossification of the calvaria), supernumerary teeth, short stature, and other skeletal changes. In some cases defects in RUNX2 are exclusively associated with dental anomalies.
See also OMIM:119600| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_064081 | 53 | Q → L in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012130 | 84 | A → AAAAAAAAAAA in CLCD; the patient also shows brachydactyly of hands and feet. 1 Publication | 1 | |
| Natural variantiVAR_012132 | 113 | L → R in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064082 | 118 | S → N in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012133 | 118 | S → R in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012134 | 121 | F → C in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012135 | 123 | C → R in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064083 | 131 | R → C in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064084 | 131 | R → G in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064085 | 131 | R → S in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012136 | 133 | Missing in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064086 | 136 | L → P in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064087 | 156 | V → D in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064088 | 156 | V → G in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064089 | 169 | R → P in CLCD. 2 PublicationsCorresponds to variant dbSNP:rs104893995Ensembl. | 1 | |
| Natural variantiVAR_012137 | 169 | R → Q in CLCD. 1 PublicationCorresponds to variant dbSNP:rs104893995Ensembl. | 1 | |
| Natural variantiVAR_064090 | 175 | M → K in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012138 | 175 | M → R in CLCD; abolishes DNA binding. 2 PublicationsCorresponds to variant dbSNP:rs104893989Ensembl. | 1 | |
| Natural variantiVAR_064091 | 175 | M → V in CLCD. 1 PublicationCorresponds to variant dbSNP:rs201647225Ensembl. | 1 | |
| Natural variantiVAR_064092 | 187 | F → S in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012139 | 190 | R → Q in CLCD; abolishes DNA binding. 1 Publication | 1 | |
| Natural variantiVAR_012140 | 190 | R → W in CLCD; has severely impaired DNA binding and transactivation. 3 Publications | 1 | |
| Natural variantiVAR_012141 | 191 | S → N in CLCD; abolishes DNA binding. 2 PublicationsCorresponds to variant dbSNP:rs104893990Ensembl. | 1 | |
| Natural variantiVAR_012142 | 193 | R → C in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064093 | 193 | R → Q in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012143 | 197 | F → S in CLCD; retains heterodimerization activity together with a trace potential for DNA binding; retains a low but still substantial transactivation activity. 2 Publications | 1 | |
| Natural variantiVAR_012144 | 199 | L → F in CLCD; abolishes DNA binding. 1 Publication | 1 | |
| Natural variantiVAR_012145 | 200 | T → A in CLCD; mild; associated also with isolated dental anomalies; normal DNA binding. 1 PublicationCorresponds to variant dbSNP:rs104893993Ensembl. | 1 | |
| Natural variantiVAR_064094 | 200 | T → I in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064095 | 201 | I → K in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012146 | 205 | T → R in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064096 | 209 | Q → H in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012147 | 209 | Q → R in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064097 | 211 | A → P in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064098 | 218 | K → E in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064099 | 218 | K → N in CLCD; has severely impaired DNA binding and transactivation. 1 PublicationCorresponds to variant dbSNP:rs752933596Ensembl. | 1 | |
| Natural variantiVAR_064100 | 218 | K → Q in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064101 | 220 | T → I in CLCD; has severely impaired DNA binding and transactivation. 1 Publication | 1 | |
| Natural variantiVAR_064102 | 225 | R → L in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012148 | 225 | R → Q in CLCD; interferes with nuclear localization; abolishes DNA binding. 5 PublicationsCorresponds to variant dbSNP:rs104893991Ensembl. | 1 | |
| Natural variantiVAR_012149 | 225 | R → W in CLCD; interferes with nuclear localization; has severely impaired DNA binding and transactivation. 4 PublicationsCorresponds to variant dbSNP:rs104893992Ensembl. | 1 | |
| Natural variantiVAR_064103 | 228 | R → G in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064104 | 233 | K → R in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064105 | 287 | D → N in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064106 | 362 | A → V in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064107 | 420 | T → I in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064108 | 420 | T → N in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012150 | 511 | G → S in CLCD; unknown pathological significance. 1 PublicationCorresponds to variant dbSNP:rs11498198Ensembl. | 1 |
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly (MDMHB)1 Publication
The disease is caused by mutations affecting the gene represented in this entry. Analysis for copy-number variations revealed that a 105 kb duplication within RUNX2 segregated with the MDMHB phenotype in a region with maximum linkage. Real-time PCR for copy-number variation in genomic DNA in eight samples, as well as sequence analysis of fibroblast cDNA from one subject with MDMHB confirmed that affected family members were heterozygous for the presence of an intragenic duplication encompassing exons 3 to 5 of RUNX2. These three exons code for the Q/A domain and the functionally essential DNA-binding Runt domain of RUNX2. The RUNX2 duplication found in individuals with MDMHB leads to a gain of function (PubMed:23290074).1 Publication
Disease descriptionAn autosomal dominant bone dysplasia characterized by metaphyseal flaring of long bones, enlargement of the medial halves of the clavicles, maxillary hypoplasia, variable brachydactyly, and dystrophic teeth.
See also OMIM:156510Mutagenesis
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Mutagenesisi | 451 | S → A: Reduced DNA-binding and impaired phosphorylation. 1 Publication | 1 |
Keywords - Diseasei
Disease mutationOrganism-specific databases
| DisGeNETi | 860. |
| MalaCardsi | RUNX2. |
| MIMi | 119600. phenotype. 156510. phenotype. |
| OpenTargetsi | ENSG00000124813. |
| Orphaneti | 1452. Cleidocranial dysplasia. 2504. Metaphyseal dysplasia - maxillary hypoplasia - brachydacty. |
| PharmGKBi | PA34885. |
Polymorphism and mutation databases
| BioMutai | RUNX2. |
| DMDMi | 17368460. |
PTM / Processingi
Molecule processing
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| ChainiPRO_0000174659 | 1 – 521 | Runt-related transcription factor 2Add BLAST | 521 |
Amino acid modifications
| Feature key | Position(s) | DescriptionActions | Graphical view | Length | |
|---|---|---|---|---|---|
| Modified residuei | 267 | Asymmetric dimethylarginineBy similarity | 1 | ||
| Modified residuei | 451 | Phosphoserine; by CDK11 Publication | 1 | ||
| Isoform 3 (identifier: Q13950-3) | |||||
| Modified residuei | 340 | PhosphoserineCombined sources | 1 | ||
Post-translational modificationi
Phosphorylated; probably by MAP kinases (MAPK). Phosphorylation by HIPK3 is required for the SPEN/MINT and FGF2 transactivation during osteoblastic differentiation (By similarity). Phosphorylation at Ser-451 by CDK1 promotes endothelial cell proliferation required for tumor angiogenesis probably by facilitating cell cycle progression. Isoform 3 is phosphorylated on Ser-340.By similarity1 Publication
Keywords - PTMi
Methylation, PhosphoproteinProteomic databases
| EPDi | Q13950. |
| MaxQBi | Q13950. |
| PaxDbi | Q13950. |
| PeptideAtlasi | Q13950. |
| PRIDEi | Q13950. |
PTM databases
| iPTMneti | Q13950. |
| PhosphoSitePlusi | Q13950. |
| SwissPalmi | Q13950. |
Expressioni
Tissue specificityi
Specifically expressed in osteoblasts.
Gene expression databases
| Bgeei | ENSG00000124813. |
| CleanExi | HS_RUNX2. |
| ExpressionAtlasi | Q13950. baseline and differential. |
| Genevisiblei | Q13950. HS. |
Organism-specific databases
| HPAi | CAB008374. CAB062561. CAB068226. HPA022040. |
Interactioni
Subunit structurei
Heterodimer of an alpha and a beta subunit. The alpha subunit binds DNA as a monomer and through the Runt domain. DNA-binding is increased by heterodimerization. Interacts with XRCC6 (Ku70) and XRCC5 (Ku80). Interacts with HIVEP3. Interacts with IFI204. Interaction with SATB2; the interaction results in enhanced DNA binding and transactivation by these transcription factors. Binds to HIPK3. Interacts (isoform 3) with DDX5. Interacts with FOXO1 (via a C-terminal region); the interaction inhibits RUNX2 transcriptional activity towards BGLAP. This interaction is prevented on insulin or IGF1 stimulation as FOXO1 is exported from the nucleus (By similarity). Interacts with CCNB1, KAT6A and KAT6B. Interacts with FOXP3. Interacts with TMEM119 (By similarity).By similarity4 Publications
Binary interactionsi
GO - Molecular functioni
- bHLH transcription factor binding Source: Ensembl
- protein domain specific binding Source: Ensembl
- repressing transcription factor binding Source: Ensembl
Protein-protein interaction databases
| BioGridi | 107308. 45 interactors. |
| DIPi | DIP-36707N. |
| IntActi | Q13950. 6 interactors. |
| MINTi | MINT-219985. |
| STRINGi | 9606.ENSP00000360493. |
Structurei
3D structure databases
| ProteinModelPortali | Q13950. |
| SMRi | Q13950. |
| ModBasei | Search... |
| MobiDBi | Search... |
Family & Domainsi
Domains and Repeats
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Domaini | 101 – 229 | RuntPROSITE-ProRule annotationAdd BLAST | 129 |
Region
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Regioni | 242 – 258 | Required for interaction with FOXO1By similarityAdd BLAST | 17 | |
| Regioni | 336 – 439 | Interaction with KAT6ABy similarityAdd BLAST | 104 | |
| Regioni | 374 – 468 | Interaction with KAT6B1 PublicationAdd BLAST | 95 |
Compositional bias
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Compositional biasi | 49 – 71 | Poly-GlnAdd BLAST | 23 | |
| Compositional biasi | 73 – 89 | Poly-AlaAdd BLAST | 17 | |
| Compositional biasi | 237 – 521 | Pro/Ser/Thr-richAdd BLAST | 285 |
Domaini
A proline/serine/threonine rich region at the C-terminus is necessary for transcriptional activation of target genes and contains the phosphorylation sites.
Phylogenomic databases
| eggNOGi | KOG3982. Eukaryota. ENOG4111J4Y. LUCA. |
| GeneTreei | ENSGT00390000016964. |
| HOGENOMi | HOG000045616. |
| HOVERGENi | HBG060268. |
| InParanoidi | Q13950. |
| KOi | K09278. |
| OMAi | SDPRQFT. |
| PhylomeDBi | Q13950. |
| TreeFami | TF321496. |
Family and domain databases
| Gene3Di | 2.60.40.720. 1 hit. 4.10.770.10. 1 hit. |
| InterProi | View protein in InterPro IPR000040. AML1_Runt. IPR008967. p53-like_TF_DNA-bd. IPR012346. p53/RUNT-type_TF_DNA-bd. IPR013524. Runt_dom. IPR027384. Runx_central_dom. IPR013711. RunxI_C_dom. IPR016554. TF_Runt-rel_RUNX. |
| PANTHERi | PTHR11950. PTHR11950. 1 hit. |
| Pfami | View protein in Pfam PF00853. Runt. 1 hit. PF08504. RunxI. 1 hit. |
| PIRSFi | PIRSF009374. TF_Runt-rel_RUNX. 1 hit. |
| PRINTSi | PR00967. ONCOGENEAML1. |
| SUPFAMi | SSF49417. SSF49417. 1 hit. |
| PROSITEi | View protein in PROSITE PS51062. RUNT. 1 hit. |
Sequences (3)i
Sequence statusi: Complete.
This entry describes 3 isoformsi produced by alternative splicing. AlignAdd to basket
Isoform 1 (identifier: Q13950-1) [UniParc]FASTAAdd to basket
Also known as: Cbfa1a
This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
10 20 30 40 50
MASNSLFSTV TPCQQNFFWD PSTSRRFSPP SSSLQPGKMS DVSPVVAAQQ
60 70 80 90 100
QQQQQQQQQQ QQQQQQQQQQ QEAAAAAAAA AAAAAAAAAV PRLRPPHDNR
110 120 130 140 150
TMVEIIADHP AELVRTDSPN FLCSVLPSHW RCNKTLPVAF KVVALGEVPD
160 170 180 190 200
GTVVTVMAGN DENYSAELRN ASAVMKNQVA RFNDLRFVGR SGRGKSFTLT
210 220 230 240 250
ITVFTNPPQV ATYHRAIKVT VDGPREPRRH RQKLDDSKPS LFSDRLSDLG
260 270 280 290 300
RIPHPSMRVG VPPQNPRPSL NSAPSPFNPQ GQSQITDPRQ AQSSPPWSYD
310 320 330 340 350
QSYPSYLSQM TSPSIHSTTP LSSTRGTGLP AITDVPRRIS DDDTATSDFC
360 370 380 390 400
LWPSTLSKKS QAGASELGPF SDPRQFPSIS SLTESRFSNP RMHYPATFTY
410 420 430 440 450
TPPVTSGMSL GMSATTHYHT YLPPPYPGSS QSQSGPFQTS STPYLYYGTS
460 470 480 490 500
SGSYQFPMVP GGDRSPSRML PPCTTTSNGS TLLNPNLPNQ NDGVDADGSH
510 520
SSSPTVLNSS GRMDESVWRP Y
Experimental Info
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Sequence conflicti | 16 | N → S in AAC77441 (PubMed:9651525).Curated | 1 |
Natural variant
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_064081 | 53 | Q → L in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012131 | 78 – 83 | Missing 1 Publication | 6 | |
| Natural variantiVAR_012130 | 84 | A → AAAAAAAAAAA in CLCD; the patient also shows brachydactyly of hands and feet. 1 Publication | 1 | |
| Natural variantiVAR_012132 | 113 | L → R in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064082 | 118 | S → N in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012133 | 118 | S → R in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012134 | 121 | F → C in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012135 | 123 | C → R in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064083 | 131 | R → C in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064084 | 131 | R → G in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064085 | 131 | R → S in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012136 | 133 | Missing in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064086 | 136 | L → P in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064087 | 156 | V → D in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064088 | 156 | V → G in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064089 | 169 | R → P in CLCD. 2 PublicationsCorresponds to variant dbSNP:rs104893995Ensembl. | 1 | |
| Natural variantiVAR_012137 | 169 | R → Q in CLCD. 1 PublicationCorresponds to variant dbSNP:rs104893995Ensembl. | 1 | |
| Natural variantiVAR_064090 | 175 | M → K in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012138 | 175 | M → R in CLCD; abolishes DNA binding. 2 PublicationsCorresponds to variant dbSNP:rs104893989Ensembl. | 1 | |
| Natural variantiVAR_064091 | 175 | M → V in CLCD. 1 PublicationCorresponds to variant dbSNP:rs201647225Ensembl. | 1 | |
| Natural variantiVAR_064092 | 187 | F → S in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012139 | 190 | R → Q in CLCD; abolishes DNA binding. 1 Publication | 1 | |
| Natural variantiVAR_012140 | 190 | R → W in CLCD; has severely impaired DNA binding and transactivation. 3 Publications | 1 | |
| Natural variantiVAR_012141 | 191 | S → N in CLCD; abolishes DNA binding. 2 PublicationsCorresponds to variant dbSNP:rs104893990Ensembl. | 1 | |
| Natural variantiVAR_012142 | 193 | R → C in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064093 | 193 | R → Q in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012143 | 197 | F → S in CLCD; retains heterodimerization activity together with a trace potential for DNA binding; retains a low but still substantial transactivation activity. 2 Publications | 1 | |
| Natural variantiVAR_012144 | 199 | L → F in CLCD; abolishes DNA binding. 1 Publication | 1 | |
| Natural variantiVAR_012145 | 200 | T → A in CLCD; mild; associated also with isolated dental anomalies; normal DNA binding. 1 PublicationCorresponds to variant dbSNP:rs104893993Ensembl. | 1 | |
| Natural variantiVAR_064094 | 200 | T → I in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064095 | 201 | I → K in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012146 | 205 | T → R in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064096 | 209 | Q → H in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012147 | 209 | Q → R in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064097 | 211 | A → P in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064098 | 218 | K → E in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064099 | 218 | K → N in CLCD; has severely impaired DNA binding and transactivation. 1 PublicationCorresponds to variant dbSNP:rs752933596Ensembl. | 1 | |
| Natural variantiVAR_064100 | 218 | K → Q in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064101 | 220 | T → I in CLCD; has severely impaired DNA binding and transactivation. 1 Publication | 1 | |
| Natural variantiVAR_064102 | 225 | R → L in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012148 | 225 | R → Q in CLCD; interferes with nuclear localization; abolishes DNA binding. 5 PublicationsCorresponds to variant dbSNP:rs104893991Ensembl. | 1 | |
| Natural variantiVAR_012149 | 225 | R → W in CLCD; interferes with nuclear localization; has severely impaired DNA binding and transactivation. 4 PublicationsCorresponds to variant dbSNP:rs104893992Ensembl. | 1 | |
| Natural variantiVAR_064103 | 228 | R → G in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064104 | 233 | K → R in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064105 | 287 | D → N in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064106 | 362 | A → V in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064107 | 420 | T → I in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_064108 | 420 | T → N in CLCD. 1 Publication | 1 | |
| Natural variantiVAR_012150 | 511 | G → S in CLCD; unknown pathological significance. 1 PublicationCorresponds to variant dbSNP:rs11498198Ensembl. | 1 |
Alternative sequence
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Alternative sequenceiVSP_005937 | 1 – 19 | MASNS…QNFFW → MRIPV in isoform 2. CuratedAdd BLAST | 19 | |
| Alternative sequenceiVSP_005938 | 341 – 362 | Missing in isoform 3. 1 PublicationAdd BLAST | 22 |
Sequence databases
| Select the link destinations: EMBLi GenBanki DDBJi Links Updated | AF001450 AF001449 Genomic DNA. Translation: AAB65159.2. AF001450 AF001449 Genomic DNA. Translation: AAB65158.1. AL161907, AL096865, AL358135 Genomic DNA. Translation: CAI19638.1. AL161907, AL096865, AL358135 Genomic DNA. Translation: CAI19639.1. AL358135, AL096865, AL161907 Genomic DNA. Translation: CAI13528.1. AL358135, AL096865, AL161907 Genomic DNA. Translation: CAI13531.1. AL096865, AL161907, AL358135 Genomic DNA. Translation: CAI19925.1. AL096865, AL161907, AL358135 Genomic DNA. Translation: CAI19931.1. AF053952 mRNA. Translation: AAC78624.1. AF053949 Genomic DNA. Translation: AAC77441.1. L40992 mRNA. Translation: AAA89072.1. |
| CCDSi | CCDS43467.2. [Q13950-1] CCDS43468.2. [Q13950-3] |
| RefSeqi | NP_001015051.3. NM_001015051.3. [Q13950-3] NP_001019801.3. NM_001024630.3. [Q13950-1] |
| UniGenei | Hs.535845. |
Genome annotation databases
| Ensembli | ENST00000359524; ENSP00000352514; ENSG00000124813. [Q13950-2] ENST00000371432; ENSP00000360486; ENSG00000124813. [Q13950-3] ENST00000371436; ENSP00000360491; ENSG00000124813. [Q13950-3] ENST00000371438; ENSP00000360493; ENSG00000124813. [Q13950-1] ENST00000465038; ENSP00000420707; ENSG00000124813. [Q13950-1] |
| GeneIDi | 860. |
| KEGGi | hsa:860. |
| UCSCi | uc003oxt.5. human. [Q13950-1] |
Keywords - Coding sequence diversityi
Alternative splicing, PolymorphismSimilar proteinsi
Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:| 100% | UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into one UniRef entry. |
| 90% | UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence). |
| 50% | UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster. |
Entry informationi
| Entry namei | RUNX2_HUMAN | |
| Accessioni | Q13950Primary (citable) accession number: Q13950 Secondary accession number(s): O14614, O14615, O95181 | |
| Entry historyi | Integrated into UniProtKB/Swiss-Prot: | November 2, 2001 |
| Last sequence update: | November 2, 2001 | |
| Last modified: | June 7, 2017 | |
| This is version 175 of the entry and version 2 of the sequence. See complete history. | ||
| Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
| Annotation program | Chordata Protein Annotation Program | |
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | |
Miscellaneousi
Keywords - Technical termi
Complete proteome, Reference proteomeDocuments
- Human chromosome 6
Human chromosome 6: entries, gene names and cross-references to MIM - Human entries with polymorphisms or disease mutations
List of human entries with polymorphisms or disease mutations - Human polymorphisms and disease mutations
Index of human polymorphisms and disease mutations - MIM cross-references
Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot
